Cellebrite DI Ltd. (CLBT)
| Market Cap | 2.97B -25.9% |
| Revenue (ttm) | 514.29M +17.8% |
| Net Income | 58.25M |
| EPS | 0.23 |
| Shares Out | 250.79M |
| PE Ratio | 51.61 |
| Forward PE | 19.31 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,772,340 |
| Open | 11.88 |
| Previous Close | 12.00 |
| Day's Range | 11.81 - 11.98 |
| 52-Week Range | 9.58 - 19.98 |
| Beta | 1.18 |
| Analysts | Strong Buy |
| Price Target | 15.36 (+29.62%) |
| Earnings Date | Aug 13, 2026 |
About CLBT
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property thef... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 8 analysts, the average rating for CLBT stock is "Strong Buy." The 12-month stock price target is $15.36, which is an increase of 29.62% from the latest price.
News
Cellebrite Guardian completes IRAP assessment
Cellebrite (CLBT) DI announced that Cellebrite Guardian has achieved an important technical milestone to support its adoption by the Company’s customers in Australia. Guardian has completed an assessm...
Cellebrite Guardian Completes IRAP Assessment: Achieves PROTECTED Level for Australian Government Agencies
Independent assessment gives Australian law enforcement, defense and national security agencies a platform for collaborating and managing digital evidence in the cloud quickly and securely TYSONS CORN...
Cellebrite achieves U.S. DOW’s advanced cybersecurity standard
Cellebrite (CLBT) announced its subsidiary, Cellebrite Federal Solutions, CFSI, achieved the advanced Cybersecurity Maturity Model Certification, CMMC, Level 2 accreditation. CMMC Level 2 is an advanc...
Cellebrite Federal Solutions, Inc. (CFSI) Achieves U.S. Department of War's Advanced Cybersecurity Standard, Reinforcing Commitment to Secure Federal Operations
TYSONS CORNER, Va., Sept. 1, 2026 /PRNewswire/ -- Cellebrite (Nasdaq: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today an...
Cellebrite Brings Battlefield Intelligence to the Armed Forces with Launch of Portable Tactical Extraction Kit (C-TEK)
Built around Cellebrite's industry-leading digital forensics capabilities, C-TEK helps forward-deployed teams quickly triage data from phones, SIM cards, drones and portable media to advance their mis...
Kaplan Fox Notifies Cellebrite DI Ltd. (CLBT) Investors of a Securities Investigation into the Company
New York, New York--(Newsfile Corp. - August 24, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ...
Kaplan Fox Announces a Securities Investigation into Cellebrite DI Ltd. (CLBT) - Investors Encouraged to Contact the Firm
New York, New York--(Newsfile Corp. - August 19, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NASDAQ...
Cellebrite Genesis for Enterprise Now Generally Available, Regional Availability Expands to More Global Markets
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 19, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Cellebrite says Shiven Ramji to succeed Thomas Hogan as CEO
Cellebrite (CLBT) announced that Shiven Ramji, who joined Cellebrite as President, Products and Technology in May 2026, has succeeded Thomas Hogan as the company’s CEO as part of a planned…
Cellebrite price target lowered to $15 from $23 at TD Cowen
TD Cowen lowered the firm’s price target on Cellebrite (CLBT) to $15 from $23 and keeps a Buy rating on the shares following Q2 results. Cellebrite missed consensus and lowered…
Cellebrite price target lowered to $16 from $20 at JPMorgan
JPMorgan analyst Brian Essex lowered the firm’s price target on Cellebrite (CLBT) to $16 from $20 and keeps an Overweight rating on the shares.
Cellebrite price target lowered to $14 from $20 at Deutsche Bank
Deutsche Bank lowered the firm’s price target on Cellebrite (CLBT) to $14 from $20 and keeps a Buy rating on the shares.
Cellebrite price target lowered to $15 from $21 at Lake Street
Lake Street lowered the firm’s price target on Cellebrite (CLBT) to $15 from $21 and keeps a Buy rating on the shares after the company missed its Q2 ARR expectations…
Cellebrite price target lowered to $12.50 from $15 at Needham
Needham lowered the firm’s price target on Cellebrite (CLBT) to $12.50 from $15 and keeps a Buy rating on the shares. Cellebrite made the surprise announcement that Shiven Ramji is…
CLBT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Cellebrite DI Ltd.
Cellebrite DI Ltd. shares dropped over 30% after the Company reported Q2 2026 revenue of approximately $131.1 million and cut its full-year 2026 ARR and revenue guidance -- SueWallSt notifies investor...
Cellebrite DI Earnings Call Transcript: Q2 2026
Q2 ARR grew 21% to $508M but missed guidance due to delayed large deals and lower Inseyets uplift. Revenue rose 16% year-over-year, with strong federal and defense growth. Full-year ARR and revenue guidance lowered, but adjusted EBITDA target raised, reflecting disciplined execution.
Cellebrite DI Earnings release: Q2 2026
Cellebrite DI released its Q2 2026 earnings on August 13, 2026, summarizing the period's financial results.
Cellebrite DI Slides: Q2 2026
Cellebrite DI has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 13, 2026.
Cellebrite Appoints Shiven Ramji Chief Executive Officer, Succeeding Thomas E. Hogan
Company Reports Second-Quarter 2026 Results ; Company Lowers Full-Year 2026 ARR and Revenue Outlook and Raises Adjusted EBITDA Target TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 13, 2026 /PRNewsw...
Cellebrite price target raised to $22 from $20 at DA Davidson
DA Davidson analyst Rudy Kessinger raised the firm’s price target on Cellebrite (CLBT) to $22 from $20 and keeps a Buy rating on the shares.
Cellebrite to Report Second-Quarter 2026 Financial Results on August 13, 2026
TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 21, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Cellebrite expands partnership with SkySafe
Cellebrite (CLBT) DI announced an expanded partnership with SkySafe. The exclusive partnership combines advanced digital forensics with advanced drone detection, deep analysis and drone activity, equi...
Cellebrite Expands Exclusive SkySafe Partnership to Deliver Immediate Drone Detection and Airspace Intelligence for Digital Investigations at Scale
The partnership unifies what happens in the sky with what's stored on the drone in a single investigative workflow TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 8, 2026 /PRNewswire/ -- Cellebrite D...